Evaluate the Efficacy and Safety of HIF-PHI for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of the study is to determin whether HIF-PHI is safe and effective in the treatment of anemia and meanwhile reduces the risk of cardiovascular and cerebrovascular events in patients who have just initiated dialysis.
Epistemonikos ID: 4cde210748692e0d7ca5c61037f00cf3efa6f76a
First added on: May 06, 2024